Skip to main content

Animations

MJFF Publications

4661 - 4670 of 8818 Results
Title
Year
  • Year
  • 2024
  • 2018
  • 2020
  • 2024
  • 2024
  • 2020
  • 2021
  • 2021
  • 2024
  • 2018
  • Summary Details
    OPEN
    Title: Deep learning‐based BMI inference from structural brain MRI reflects brain alterations following lifestyle intervention
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26595
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.12591
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12921
    Citation Count: 260
  • Summary Details
    OPEN
    Title: Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13658
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and framework
    Journal Name: Frontiers in Systems Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fsysb.2024.1351555
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4725
    Citation Count: 111
  • Summary Details
    OPEN
    Title: Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.5257
    Citation Count: 153
  • Summary Details
    OPEN
    Title: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4222
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.52034
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease
    Journal Name: PeerJ
    Publisher: PeerJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7717/peerj.5308
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.